Literature DB >> 16699023

Deletion of open reading frame UL26 from the human cytomegalovirus genome results in reduced viral growth, which involves impaired stability of viral particles.

Kerstin Lorz1, Heike Hofmann, Anja Berndt, Nina Tavalai, Regina Mueller, Ursula Schlötzer-Schrehardt, Thomas Stamminger.   

Abstract

We previously showed that open reading frame (ORF) UL26 of human cytomegalovirus, a member of the US22 multigene family of betaherpesviruses, encodes a novel tegument protein, which is imported into cells in the course of viral infection. Moreover, we demonstrated that pUL26 contains a strong transcriptional activation domain and is capable of stimulating the major immediate-early (IE) enhancer-promoter. Since this suggested an important function of pUL26 during the initiation of the viral replicative cycle, we sought to ascertain the relevance of pUL26 by construction of a viral deletion mutant lacking the UL26 ORF using the bacterial artificial chromosome mutagenesis procedure. The resulting deletion virus was verified by PCR, enzyme restriction, and Southern blot analyses. After infection of human foreskin fibroblasts, the UL26 deletion mutant showed a small-plaque phenotype and replicated to significantly lower titers than wild-type or revertant virus. In particular, we noticed a striking decrease of infectious titers 7 days postinfection in a multistep growth experiment, whereas the release of viral DNA from infected cells was not impaired. A further investigation of this aspect revealed a significantly diminished stability of viral particles derived from the UL26 deletion mutant. Consistent with this, we observed that the tegument composition of the deletion mutant deviates from that of the wild-type virus. We therefore hypothesize that pUL26 plays a role not only in the onset of IE gene transcription but also in the assembly of the viral tegument layer in a stable and correct manner.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699023      PMCID: PMC1472153          DOI: 10.1128/JVI.02585-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Human cytomegalovirus late-phase maturation is blocked by stably expressed UL32 antisense mRNA in astrocytoma cells.

Authors:  H H Meyer; A Ripalti; M P Landini; K Radsak; H F Kern; G M Hensel
Journal:  J Gen Virol       Date:  1997-10       Impact factor: 3.891

2.  The functionally active IE2 immediate-early regulatory protein of human cytomegalovirus is an 80-kilodalton polypeptide that contains two distinct activator domains and a duplicated nuclear localization signal.

Authors:  M C Pizzorno; M A Mullen; Y N Chang; G S Hayward
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome.

Authors:  M Messerle; I Crnkovic; W Hammerschmidt; H Ziegler; U H Koszinowski
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

4.  Versatile insertion plasmids for targeted genome manipulations in bacteria: isolation, deletion, and rescue of the pathogenicity island LEE of the Escherichia coli O157:H7 genome.

Authors:  G Pósfai; M D Koob; H A Kirkpatrick; F R Blattner
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

5.  Temporal regulation of human cytomegalovirus transcription at immediate early and early times after infection.

Authors:  M W Wathen; D R Thomsen; M F Stinski
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

6.  Expression and characterization of a novel structural protein of human cytomegalovirus, pUL25.

Authors:  M C Battista; G Bergamini; M C Boccuni; F Campanini; A Ripalti; M P Landini
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle.

Authors:  C J Baldick; A Marchini; C E Patterson; T Shenk
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic compartment which overlaps the endoplasmic reticulum-golgi-intermediate compartment.

Authors:  V Sanchez; E Sztul; W J Britt
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  A specific subform of the human cytomegalovirus transactivator protein pUL69 is contained within the tegument of virus particles.

Authors:  M Winkler; T Stamminger
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

10.  Human cytomegalovirus tegument protein ppUL35 is important for viral replication and particle formation.

Authors:  Karina Schierling; Christopher Buser; Thomas Mertens; Michael Winkler
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

View more
  43 in total

1.  The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.

Authors:  Thomas Goldner; Guy Hewlett; Nicole Ettischer; Helga Ruebsamen-Schaeff; Holger Zimmermann; Peter Lischka
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

2.  Human cytomegalovirus UL28 and UL29 open reading frames encode a spliced mRNA and stimulate accumulation of immediate-early RNAs.

Authors:  Dora P Mitchell; John P Savaryn; Nathaniel J Moorman; Thomas Shenk; Scott S Terhune
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

3.  Nuclear trafficking of the human cytomegalovirus pp71 (ppUL82) tegument protein.

Authors:  Weiping Shen; Elizabeth Westgard; Liqun Huang; Michael D Ward; Jodi L Osborn; Nha H Chau; Lindsay Collins; Benjamin Marcum; Margaret A Koach; Jennifer Bibbs; O John Semmes; Julie A Kerry
Journal:  Virology       Date:  2008-04-18       Impact factor: 3.616

4.  Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections.

Authors:  Nina Tavalai; Peer Papior; Sabine Rechter; Martina Leis; Thomas Stamminger
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  pUL69 of Human Cytomegalovirus Recruits the Cellular Protein Arginine Methyltransferase 6 via a Domain That Is Crucial for mRNA Export and Efficient Viral Replication.

Authors:  Marco Thomas; Eric Sonntag; Regina Müller; Stefanie Schmidt; Barbara Zielke; Torgils Fossen; Thomas Stamminger
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

6.  Cytomegalovirus UL103 controls virion and dense body egress.

Authors:  Jenny Ahlqvist; Edward Mocarski
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

7.  Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle.

Authors:  Nina Tavalai; Martina Adler; Myriam Scherer; Yvonne Riedl; Thomas Stamminger
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

8.  Centrosomal protein TRIM43 restricts herpesvirus infection by regulating nuclear lamina integrity.

Authors:  Florian Full; Michiel van Gent; Konstantin M J Sparrer; Cindy Chiang; Matthew A Zurenski; Myriam Scherer; Norbert H Brockmeyer; Lucie Heinzerling; Michael Stürzl; Klaus Korn; Thomas Stamminger; Armin Ensser; Michaela U Gack
Journal:  Nat Microbiol       Date:  2018-11-12       Impact factor: 17.745

9.  Cyclin-dependent Kinases Phosphorylate the Cytomegalovirus RNA Export Protein pUL69 and Modulate Its Nuclear Localization and Activity.

Authors:  Sabine Rechter; Gillian M Scott; Jan Eickhoff; Katrin Zielke; Sabrina Auerochs; Regina Müller; Thomas Stamminger; William D Rawlinson; Manfred Marschall
Journal:  J Biol Chem       Date:  2009-01-29       Impact factor: 5.157

10.  The Abundant Tegument Protein pUL25 of Human Cytomegalovirus Prevents Proteasomal Degradation of pUL26 and Supports Its Suppression of ISGylation.

Authors:  Christine Zimmermann; Nicole Büscher; Steffi Krauter; Nadine Krämer; Uwe Wolfrum; Elisabeth Sehn; Stefan Tenzer; Bodo Plachter
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.